Highlights Human IPSC-Derived PreBötC-Like Neurons and Development of an Opiate Overdose and Recovery Model, published in 2023 by Hesperos in Advanced Biology, has been recognized as a top viewed article in the journal.The study describes the … Read More
The U.S. Food and Drug Administration announced a Roadmap to Reducing Animal Testing in Preclinical Safety Studies by leveraging more effective, human relevant methods including technologies like our Human-on-a-Chip! This exciting announcement outlines a 3-year strategic … Read More
Our team had the privilege of the Society of Toxicology (SOT) Annual Meeting and ToxExpo 2025 March 16-20th. SOT brought experts in the field of toxicology together for five days of scientific sessions, poster presentations, and … Read More
In loving memory of Jeffrey M. Anderson February 16, 1957 – March 1, 2025 We are deeply saddened to announce the passing of Jeffrey M. Anderson, PhD. Dr. Anderson passed away on March 1, 2025, after … Read More
“[This] is a demonstration of how these novel technologies can be leveraged to develop a new treatment paradigm – moving away from the one-treatment-fits-all perspective and towards the development of personalized medicines,” Mihael H. Polymeropoulos, M.D., … Read More
Ask Me Anything: Body-On-A-Chip Michael Shuler, PhD was featured on Technology Network’s Ask Me Anything: Body-On-A-Chip webinar and answered questions from a live audience. January 31, 2025: Hosted by Technology Networks, Hesperos President Michael Shuler, PhD, … Read More
ORLANDO, FLORIDA – Researchers from Hesperos and the University of Central Florida have developed a groundbreaking model using human induced pluripotent stem cell (iPSC)-derived cortical neurons to better understand and combat Alzheimer’s disease (AD). Their research, published in Alzheimer’s and Dementia, aims to improve our understanding and treatment of the disease.